Cost Plus Marketplace adds AFT’s Combogesic
The partnership with Mark Cuban Cost Plus Marketplace expands U.S. access to AFT Pharmaceuticals’ prescription non-opioid pain treatment.
Mark Cuban Cost Plus Drug Co.
Paytient expands prescription benefit platform with GoodRx and Cost Plus Drugs
New offering combines prescription savings with interest-free payments to improve adherence and reduce employer healthcare costs.
Bristol Myers Squibb and Pfizer to make Eliquis (apixaban) available via Mark Cuban Cost Plus Drug Co.
Expands options for cash-paying patients to access the nation’s No. 1 prescribed oral blood thinner
Mark Cuban Cost Plus Drug Co. expands access with addition of Starjemza
New biosimilar added to portfolio reinforces the company's commitment to transparency and access.